Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

994496

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Tramadol
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to limit the prescription of Tramadol.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	183935
answer	answer is ministerial correction date of answer 31/10/2018 answer text <p>The Department expects all clinicians to act responsibly when prescribing schedule three drugs such as Tramadol. The responsibility for prescribing and any necessary follow-up rests with the doctor or prescriber who has clinical responsibility for that particular aspect of a patient's care. Decisions on which drugs are prescribed should be based on clinical assessments. Good communication between practitioners and patients is essential and prescribers should always involve patients in decisions about the treatment proposed, including informing them of any possible side effects from their prescribed medicines.</p><p> </p><p>The Advisory Council on the Misuse of Drugs published advice on the use of Tramadol in 2013. This advice can be found at the following link:</p><p> </p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144116/advice-tramadol.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/144116/advice-tramadol.pdf</a></p><p> </p><p>Advice to prescribers includes warnings that repeated use is associated with psychological and physical dependence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/10/2018 12:09:42 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

994497

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to introduce the new blood test for breast cancer screening to improve the rate of early diagnosis.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	183936
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>There are no immediate plans to introduce the new blood test into screening or referral pathways. This is not included in National Institute for Health and Care Excellence Guidelines (NG101) on referral and diagnosis (published in July 2018).</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:33:28 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

994559

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the (a) diagnosis and (b) treatment of lung cancer.
tabling member constituency	Mansfield
tabling member printed	Ben Bradley
uin	183959
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>NHS England is extending targeted lung health checks to clinical commissioning groups with high mortality rates and high incidence of lung cancer. In Greater Manchester, introducing low dose CT health checks saw an almost five-fold reduction in stage 4 disease, with 80% of cancers diagnosed at an early stage.</p><p> </p><p>A new cancer diagnosis standard, designed to ensure that patients find out within 28 days whether or not they have cancer, will be introduced in 2020. NHS England has published guidance for lung cancer on how to speed up the start of the pathway, to meet this new standard and to maximise the number of patients who might benefit from potentially curative surgery. The National Health Service has been asked to implement this pathway in Refreshing NHS Plans for 2018/19 (annual planning guidance). Transformation funding was provided to Cancer Alliances in 2018/19 to ensure the pathway will be implemented across England. Guidance on the best practice timed diagnosis pathways is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/rapid-cancer-diagnostic-and-assessment-pathways/" target="_blank">https://www.england.nhs.uk/publication/rapid-cancer-diagnostic-and-assessment-pathways/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:37:40 answering member 4067 label Biography information for Steve Brine
tabling member	4663 label Biography information for Ben Bradley

994562

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Medical Treatments Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department spent on travel and accommodation for adults taking part in the NHS Proton Beam Therapy Service Overseas programme in (a) 2010, (b) 2015, (c) 2016 and (d) 2017.
tabling member constituency	Harlow
tabling member printed	Robert Halfon
uin	183919
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>NHS England’s financial data for the National Health Service Proton Beam Therapy (PBT) Service Overseas programme does not differentiate between adults and children. Data for 2010 data is unavailable as this is before the creation of NHS England.</p><p> </p><p>The costs per year from 2013/14 to 2017/18 are in the following table.</p><p> </p><p>Cost of PBT Overseas patients 2013/14 to 2017/18 (£ million)</p><table><tbody><tr><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p>£9.13</p></td><td><p>£12.63</p></td><td><p>£20.81</p></td><td><p>£24.51</p></td><td><p>£22.75</p></td></tr></tbody></table><p> </p><p>This includes accommodation.</p><p> </p><p>Travel cost figures are available in the following table. It should be noted that figures are only available for 2016/17 and 2017/18.</p><p> </p><p>Cost of PBT Overseas patients travel 2013/14 to 2017/18 (£ thousand)</p><table><tbody><tr><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p>£0.44</p></td><td><p>£0.50</p></td></tr></tbody></table><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 183920 question first answered 02/11/2018 13:36:14 answering member 4067 label Biography information for Steve Brine
tabling member	3985 label Biography information for Robert Halfon

994563

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Radiotherapy: Medical Treatments Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much his Department spent on travel and accommodation for children taking part in the NHS Proton Beam Therapy Service Overseas programme in (a) 2010, (b) 2015, (c) 2016 and (d) 2017.
tabling member constituency	Harlow
tabling member printed	Robert Halfon
uin	183920
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>NHS England’s financial data for the National Health Service Proton Beam Therapy (PBT) Service Overseas programme does not differentiate between adults and children. Data for 2010 data is unavailable as this is before the creation of NHS England.</p><p> </p><p>The costs per year from 2013/14 to 2017/18 are in the following table.</p><p> </p><p>Cost of PBT Overseas patients 2013/14 to 2017/18 (£ million)</p><table><tbody><tr><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p>£9.13</p></td><td><p>£12.63</p></td><td><p>£20.81</p></td><td><p>£24.51</p></td><td><p>£22.75</p></td></tr></tbody></table><p> </p><p>This includes accommodation.</p><p> </p><p>Travel cost figures are available in the following table. It should be noted that figures are only available for 2016/17 and 2017/18.</p><p> </p><p>Cost of PBT Overseas patients travel 2013/14 to 2017/18 (£ thousand)</p><table><tbody><tr><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p>£0.44</p></td><td><p>£0.50</p></td></tr></tbody></table><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 183919 question first answered 02/11/2018 13:36:14 answering member 4067 label Biography information for Steve Brine
tabling member	3985 label Biography information for Robert Halfon

994574

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information is provided by NHS England to patients with blood cancer on CAR-T cell therapies.
tabling member constituency	Alyn and Deeside
tabling member printed	Mark Tami
uin	183879
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>Clinicians are uniquely placed to explain to individual patients what treatments might or might not benefit them, with reference to their circumstances. NHS England is working with providers, patient groups and manufacturers to ensure appropriate information is made available to help clinicians and patients make informed treatment decisions as Chimeric Antigen Receptor T Cell (CAR-T) therapy starts to be made available through the National Health Service.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:31:33 answering member 4067 label Biography information for Steve Brine
tabling member	1383 label Biography information for Mark Tami

994628

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS England news releases of 5 September and 5 October, when he plans to make CAR-T cell therapy available to (a) people aged under 25 with acute lymphoblastic leukaemia and (b) adult patients with diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma after two or more previous therapies have failed.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	183918
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>NHS England is working with the manufacturers and National Health Service providers to prepare the NHS to begin delivering Chimeric Antigen Receptor T Cell (CAR-T) therapy - the first in a wave of treatments in a new era of personalised medicine and part of the NHS’s long-term plan to upgrade cancer service. The first treatment that will be available to patient is tisagenlecleucel (Kymriah) as an option for treating children and young people up to 25 years old with B cell acute lymphoblastic leukaemia that is refractory, in relapsed post-transplant or in second or later relapse.</p><p> </p><p>NHS England anticipates that the National Institute for Health and Care Excellence will recommend this treatment for entry into the Cancer Drugs Fund in mid-November. If so, funding will be made immediately available, following a successful commercial deal with the manufacturer Novartis. We anticipate the first patients will begin their treatment in late November 2018. The phased implementation required by the manufacturer and the NHS means that full capacity to treat eligible patients will take some months to achieve and a National CAR-T Clinical Panel will convene in mid-November to assure equity of access and prioritise eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:32:27 answering member 4067 label Biography information for Steve Brine
tabling member	3960 label Biography information for Henry Smith

994630

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Smoking: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effect of smoking cessation treatments on health inequalities in the UK; and if he will make an estimate of the relative uptake of smoking cessation treatments by socio-economic group.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	183884
answer	answer is ministerial correction date of answer 02/11/2018 answer text <p>The Tobacco Control Plan 2017-2022 published last year commits the Government to reduce the inequality gap in smoking prevalence between those in routine and manual occupations and the general population. Smoking cessation treatment is one part of the comprehensive approach to tobacco control required to achieve this ambition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 02/11/2018 13:39:16 answering member 4067 label Biography information for Steve Brine
tabling member	1439 label Biography information for Norman Lamb

994661

registered interest
date	25/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Head Lice
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the oral contribution of 25 October 2018 of the hon. Member for Kingston upon Hull West and Hessle, Official Report, column 456, what assessment he has made of the effect that recent changes to NHS guidance to Clinical Commissioning Groups on conditions for which over the counter items should not routinely be prescribed in primary care will have on the spread of headlice in deprived areas.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	183990
answer	answer is ministerial correction date of answer 31/10/2018 answer text <p>The Department has made no such assessment. The section of NHS England’s guidance which covers head lice says that chemical treatment for them is only used in exceptional cases; the usual treatment is wet combing. NHS England undertook an Equalities and Health Inequalities analysis ‘Conditions for which over the counter items should not be routinely prescribed in primary care: Equality and health inequalities full analysis form’ alongside the guidance, which assessed the impact of the guidance on those from low income households and those living in poverty. The analysis can be accessed using the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2018/03/otc-ehi-analysis-form.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2018/03/otc-ehi-analysis-form.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/10/2018 12:08:25 answering member 4067 label Biography information for Steve Brine
tabling member	4645 label Biography information for Emma Hardy

994008

registered interest
date	24/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Prescription Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 23 April 2018 to Question 136107 on Prescription Drugs: Misuse, what steps his Department is taking to tackle the increase in deaths caused by the consumption of an excess of prescription drugs being the primary cause.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	183285
answer	answer is ministerial correction date of answer 29/10/2018 answer text <p>The Government is concerned by the increase in deaths related to the misuse of prescription opioids. The Department has commissioned a review of prescription drug dependence from Public Health England to help understand the scope of the problem. The review will provide a strong evidence base for future policy development in this area.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/10/2018 17:49:06 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell